LEMD2 Antibodies

Santa Cruz Biotechnology delivers a wide array of LEMD2 Antibodies for investigating LEMD2 in cellular processes. LEMD2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LEMD2, or Lemurian domain-containing protein 2, is a crucial component of the nuclear envelope and plays a significant role in maintaining nuclear structure and function. LEMD2 participates in chromatin organization and gene expression regulation, making it essential for proper cellular function and development. Research has shown that LEMD2 influences various cellular pathways and signaling mechanisms. Alterations in LEMD2 expression have been linked to several pathological conditions, emphasizing its relevance in disease research. Understanding LEMD2's molecular mechanisms can provide valuable insights into nuclear envelope dynamics and cellular regulation. Current research continues to uncover new functions and interactions of LEMD2 in different cellular contexts. Santa Cruz Biotechnology monoclonal antibodies for LEMD2 enable researchers to advance scientific understanding of nuclear envelope biology and disease mechanisms.